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The PTH/PTHrP Receptor Can Delay
Chondrocyte Hypertrophy In Vivo
without Activating Phospholipase C
GPCRs are not uniquely determined by the receptor
sequence but depend also upon many other factors
that may be controlled directly or indirectly by the cell’s
environment in vivo. These may include the level of re-
ceptor expression, the abundance of specific G proteins
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Massachusetts General Hospital and
Harvard Medical School
Boston, Massachusetts 02114 and other adaptor or scaffolding proteins, the expres-
sion and activity of downstream kinases and their sub-
strates, functional interactions with signals generated
Summary by ligands activating other types of receptors expressed
in the same target cell, interactions with adjacent cells,
One G protein-coupled receptor (GPCR) can activate constituents of the extracellular matrix, mechanical
more than one G protein, but the physiologic impor- forces in the tissue, and local or systemic regulatory
tance of such activation has not been demonstrated in factors. For these reasons, interdiction of specific sig-
vivo. We have generated mice expressing exclusively a naling events within the context of an otherwise normal
mutant form of the PTH/PTHrP receptor (DSEL) that intact animal is a critical step toward understanding the
activates adenylyl cyclase normally but not phospholi- physiologic roles of such multiple receptor signals.
pase C (PLC). DSEL mutant mice exhibit abnormalities Chondrocytes and osteoblasts are the primary target
in embryonic endochondral bone development, in- cells for PTHrP and PTH in bone, and both cell types
cluding delayed ossification and increased chondro- express PTH/PTHrP receptors that regulate their differ-
cyte proliferation. Analysis of the differentiation of em- entiation and function (Amizuka et al., 1999; Bos et al.,
bryonic metatarsals in vitro shows that PTH(1–34) and 1996; Langub et al., 2001; Lee et al., 1995). Chondrocytes
forskolin inhibit, whereas active phorbol ester stimu- in the murine fetal growth plate, in response to PTHrP
lates, hypertrophic differentiation. Thus, PLC signaling expressed in the periarticular region (and perhaps to
via the PTH/PTHrP receptor normally slows the prolif- circulating PTH as well), show continued proliferation
eration and hastens the differentiation of chondro- and delayed hypertrophy, effects that are disrupted by
cytes, actions that oppose the dominant effects of
ablation of the PTH/PTHrP receptor (Karaplis et al.,
PTH/PTHrP receptors and that involve cAMP-depen-
1994; Lanske et al., 1996). Periarticular expression of
dent signaling pathways.
PTHrP in fetal growth plates is stimulated by Indian
hedgehog (Ihh) synthesized by postmitotic, prehypertro-Introduction
phic chondrocytes that also express abundant PTH/
PTHrP receptors (Lee et al., 1995). By prolonging theThe parathyroid hormone (PTH)/PTH-related protein
proliferation of chondrocytes, PTHrP delays differentia-(PTHrP) receptor is a member of the B subfamily of G
tion into cells that synthesize Ihh, thereby establishingprotein-coupled receptors (GPCRs; Gether, 2000; Wess,
a negative feedback loop that controls the pace of chon-1998). This receptor can activate at least three types of
drocyte differentiation in the growth plate (Chung et al.,G proteins: Gs, which activates adenylyl cyclase (AC)/
1998; St-Jacques et al., 1999; Vortkamp et al., 1996). Inprotein kinase A (PKA), the Gq/G11 family, which activates
skeletons of adult animals, PTH increases the lineagephospholipase C (PLC)/protein kinase C (PKC), and Gi,
commitment, differentiation, and function of osteo-which can inhibit adenylyl cyclase and exert other ac-
blasts, especially those adjacent to trabecular bonetions as well (Bringhurst et al., 1993; Fujimori et al., 1992;
(Dobnig and Turner, 1995; Hock and Gera, 1992; MiaoOffermanns et al., 1996; Rappaport and Stern, 1986;
et al., 2001; Mitlak et al., 1996; Nishida et al., 1994), andSchneider et al., 1994). Utilizing these pathways, the
it also increases the formation and activity of bone-PTH/PTHrP receptor can concurrently generate multiple
resorbing osteoclasts (Dobnig and Turner, 1997; Hockintracellular second messengers, including cAMP, inosi-
and Gera, 1992; Kitazawa et al., 1991; Tam et al., 1982;tol triphosphate (IP3), diacylglycerol, and cytosolic Ca2
Uzawa et al., 1995).transients, which then may mediate specific cellular re-
Previous efforts to identify the particular intracellularsponses in target cells (Friedman et al., 1996; Guo et
signaling pathways whereby PTH/PTHrP receptors reg-al., 2001; Miao et al., 2001; Radeff et al., 2001; Swarthout
ulate the differentiation, proliferation, and function ofet al., 2001; Zhen et al., 2001). Although such multiple
chondrocytes and osteoblasts have been conductedsignaling commonly is observed with other B family re-
mainly with in vitro cell or organ culture systems, inceptors and with receptors in the A and C families of
which pharmacologic agonists or antagonists of Gs-,GPCRs as well (Francesconi and Duvoisin, 1998; Gether,
Gq/11-, or Gi-dependent responses could be introduced2000; Gudermann et al., 1996; Kukkonen et al., 2001;
Pisegna and Wank, 1996; Wess, 1998), the functional directly. Various analogs of PTH believed to signal selec-
significance of this diverse signaling has not been estab- tively via PTH/PTHrP receptors, such as PTH(1–31),
lished in vivo. This is crucial, however, since the occur- PTH(3–34), PTH(7–34), or PTH(28–48) (Fujimori et al.,
rence and intensity of specific signaling responses to 1991; Jouishomme et al., 1994; Takasu et al., 1999a),
also have been used, both in vitro and in vivo. Studies
with isolated chondrocytes in vitro, for example, have1Correspondence: hkronenberg@partners.org
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suggested that PTH/PTHrP receptors may regulate ex- and E2 of the receptor (Figure 1A). Each of four indepen-
dent loxP/Cre-targeted clones produced chimeric ani-pression of type X collagen, Bcl-2, and vitamin D recep-
tors via activation of PKC (Klaus et al., 1994; Zhen et mals and successfully contributed to germline transmis-
sion in C57BL/6 mice. Homozygotes were successfullyal., 2001), whereas the cAMP/PKA pathway may play a
primary role in controlling mineralization and synthesis derived from two independent DSEL founders, and simi-
lar phenotypes were observed in 129/SvJ/C57BL/6 ge-of alkaline phosphatase, glycosaminoglycans, Ihh, and
retinol binding protein (Kato et al., 1988; Kawashima- netic backgrounds. Heterozygous and homozygous
DSEL mice were born in the expected Mendelian ratioOhya et al., 1999; Shukunami et al., 1997; Yoshida et al.,
2001). The relative roles of PKA versus PKC in regulating (of 516 mice, 126 [24.4%] were homozygous mutants
[PTHRD/D], 122 [23.6%] were wild-type [PTHR/], andalkaline phosphatase may differ between populations
of chondrocytes isolated from distinct regions of the 268 [51.9%] were heterozygotes [PTHR/D]). Unlike mice
lacking PTH/PTHrP receptors, which die at birth or im-growth plate, however (Schwartz et al., 1997), and inves-
tigators addressing the involvement of these kinases in mediately thereafter (Lanske et al., 1996), homozygous
PTHRD/D mutants are viable, appear grossly normal, andmediating the proliferative response of chondrocytes to
PTH have reached different conclusions (Klaus et al., are fertile. Blood ionized calcium and serum phosphate
of mutant mice, measured at birth or at 4 and 8 weeks1994; Koike et al., 1990; Schluter et al., 1989; Zuscik et
al., 1994). thereafter, were normal (data not shown).
We previously described a mutant form of the PTH/
PTHrP receptor, in which a clustered DSEL sequence is
DSEL Mice Fail to Activate Phospholipase Csubstituted for the wild-type EKKY within the receptor’s
via the PTH/PTHrP Receptorsecond intracellular loop. This mutation specifically in-
Previous studies in vitro have shown that the DSEL mu-terrupts signaling via the PLC/PKC pathway but pre-
tation selectively abolishes PTH/PTHrP receptor activa-serves normal activation of adenylyl cyclase/PKA (Guo
tion of PLC, leaving adenylyl cyclase activation intactet al., 2001; Iida-Klein et al., 1997). Thus, porcine renal
(Iida-Klein et al., 1997). To confirm defective PLC activa-epithelial (LLC-PK1) cells stably transfected with DSEL
tion via mutant PTH/PTHrP receptors in PTHRD/D mice,mutant PTH/PTHrP receptors exhibited normal cAMP
we analyzed IP3 generation following PTH treatment inresponsiveness to PTH but no PLC activation and no
vitro of primary proximal tubule cells obtained fromregulation of sodium phosphate cotransport, a response
PTHR/, PTHR/D, and PTHRD/D mice. Proximal tubuleknown to be PKC dependent in these cells (Iida-Klein
cells were used for these assays because their robustet al., 1997). When expressed in clonal chondrocytes,
PLC response provides a sensitive assay for the effectin which endogenous PTH/PTHrP receptor expression
of the DSEL mutation. As expected, PTH-stimulated IP3previously had been ablated, these mutant (DSEL) re-
generation was readily measurable in proximal tubuleceptors mediated normal (PKA-dependent) regulation
cells from wild-type and PTHR/D mice but was unde-of chondrocyte differentiation by PTH (Guo et al., 2001).
tectable in cells from homozygous PTHRD/D mice (FigureTo ascertain the importance of PLC-dependent PTH/
1B). Cyclic AMP responses to PTH in all three genotypesPTHrP receptor signaling under physiologic conditions
were equivalent, and cell surface expression of mutantin vivo, in the absence of administered exogenous PTH,
DSEL receptors was normal (Figure 1B).we have generated mice that express only the DSEL,
PLC-defective form of the PTH/PTHrP receptor. Cells
isolated from these animals fail to activate PLC via the Phenotype of Early Bone Development
PTH/PTHrP receptor and show abnormal development in DSEL Mice
of endochondral bone during fetal life, including an early To determine whether PLC signaling via the PTH/PTHrP
delay in hypertrophic differentiation, blood vessel inva- receptor plays any role in normal skeletal development,
sion, and bone deposition, and a later expansion of we first performed combined Alcian blue/Alizarin red
columnar proliferating chondrocytes. This phenotype is staining of the entire skeleton of E18.5 mice. A defect
quite distinct from that observed in mice lacking the in ossification of the tail, digital, and metatarsal bones
PTH/PTHrP receptor altogether, and indicates that PLC was observed in PTHRD/D embryos, seen as an absence
signaling by this receptor normally serves to dampen or decrease in Alizarin red staining (Figure 1C). To better
the dominant chondrocyte response to PTHrP. Thus, appreciate the abnormalities in development of these
these studies establish roles for activation of multiple most distal bones and other limb bones, we examined
G proteins by one G protein-coupled receptor in vivo. them histologically. During chondrogenesis, chondro-
cyte hypertrophy normally is followed by blood vessel
invasion and deposition of bone by osteoblasts. A delay
Results in this process can be observed with either targeted
overexpression of PTHrP or targeted expression of con-
Generation and Analysis of DSEL Mice stitutively active PTH/PTHrP receptors in chondrocytes
A clustered mutation (DSEL) in the second intracellular (Schipani et al., 1997; Weir et al., 1996). In contrast,
loop of the PTH/PTHrP receptor, known to abrogate chondrocyte differentiation is accelerated following ab-
PLC but not adenylyl cyclase signaling (Iida-Klein et al., lation of either PTHrP or the PTH/PTHrP receptor (Kar-
1997), was inserted in place of the wild-type sequence aplis et al., 1994; Lanske et al., 1996). In tibias and meta-
EKKY on one allele of the receptor gene in J1 embryonic tarsals from E14.5–E18.5 PTHRD/D embryos, expansion
stem cells. In addition to the DSEL mutation, the tar- of proliferating chondrocytes and delays in both chon-
geting strategy employed produced a single residual drocyte differentiation and subsequent vascular inva-
sion and bone deposition were observed (Figure 2). AllloxP site, located within the intron between exons E1
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Figure 1. Generation and Characterization of DSEL Mutant Receptor in Mice
(A) Scheme of the genomic structure of the PTH/PTHrP receptor, the targeting vector, and DSEL-neo and DSEL alleles. In the targeting vector,
the wild-type sequence EKKY in the second intracellular loop was mutated to DSEL (*), and a new recognition site for SacI also was introduced
within the nucleotide sequence encoding the DSEL mutation. The loxP-flanked neomycin resistance cassette (neo) was inserted at an EcoRV
site in the intron between exons E1 and E2 of the receptor gene. The DSEL-neo allele represents the structure of the PTH/PTHrP receptor
locus following homologous recombination, whereas the DSEL allele illustrates the result of subsequent recombination of the two loxP sites
(filled ovals) by Cre recombinase. Positions of PCR primers (5-GATGGTACACCTACTGAGTGGTCG-3/5-AAGCGCTGCTAACCTCACACA
GGT-3) used for the detection of both wild-type and DSEL alleles are indicated by arrows, and expected sizes of PCR products were 145
and 181 bp for the wild-type and DSEL alleles, respectively, which differ only by one loxP sequence. The location of the probes used for
Southern analysis also are shown (5 probe and SacI probe); H, HindIII; S, SacI; X, XhoI; K, KpnI; R, EcoRI; RV, EcoRV; tk, PGK-thymidine
kinase cassette. The table lists the predicted sizes of restriction fragments following SacI or HindIII digestion of each allele.
(B) Analysis of receptor signaling in wild-type and DSEL mice. Primary cultures of proximal tubule cells from wild-type (/), PTHR/D
heterozygote (/D), and PTHRD/D homozygote (D/D) mice were used to measure PLC (left panel) and cAMP (middle panel) responses to
rPTH(1–34), as well as surface expression of PTH/PTHrP receptors (right panel). For measurement of PLC stimulation, cells were exposed to
rPTH(1–34) (100 nM) for 0 min (open bars), 5 min (hatched bars), or 30 min (filled bars) in the presence of 10 mM LiCl. Cell-associated cyclic
AMP was measured after incubation of cells (wild-type, open circles; PTHR/D, filled squares; PTHRD/D, filled circles) for 20 min in the presence
of 3-isobutyl-1-methylxanthine (0.5 mM) and rPTH(1–34) at the indicated concentrations. Receptor expression was measured in the presence
(filled bars) or absence (open bars) of added first antibody (G48). Results are expressed as means  SEM of triplicates of pmol/well of inositol
trisphosphate (left panel), percent of basal cAMP response (middle panel), or cpm/well of cell-associated 125I-labeled third antibody (right
panel). Similar results were obtained in two experiments of each type.
(C) Skeletal phenotypes of E18.5 embryos. Embryos harvested at E18.5 were digested free of soft tissue and then stained for both Alizarin
red (for mineralized structures) and Alcian blue (for cartilage). Upper panel: entire skeleton of a wild-type, PTHR/D heterozygote, and PTHRD/D
homozygote, showing a defect in mineralization of the tail and paws in PTHRD/D (arrows). Lower panel: paw of hindlimb skeleton.
examined bones formed by endochondral bone forma- similar to those found in the metatarsals and tibia. These
changes are most evident early in the development oftion, including calcaneous, talus, ulna, lumbar vertebrae,
and sternum (see Supplemental Figure S1 at http:// each bone and thus occur asynchronously in correspon-
dence to the differing pace of development of thesewww.developmentalcell.com/cgi/content/full/3/2/183/
DC1), exhibited delays in hypertrophy and ossification bones. These findings thus resemble those in mice with
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Figure 2. Histology of Tibial and Metatarsal Growth Plates
(A) Hematoxylin/eosin-stained longitudinal sections through wild-type (left panels) and PTHRD/D (right panels) metatarsals are shown for bones
removed at days E14.5, E15.5, E17.5, and E18.5 (includes collagen X in situ hybridization) Sections are shown at 200 magnification (except
E18.8, shown at 100). At E17.5, blood vessel invasion (arrows) and degradation of hypertrophic chondrocytes was evident in wild-type but
not yet in PTHRD/D metatarsals. CP, columnar proliferating chondrocytes.
(B) Hematoxylin/eosin-stained longitudinal sections through wild-type (/) and PTHRD/D mutant (D/D) tibiae at E14.5 (left panels, 200), and
in situ hybridization for collagen type X in tibia at E15.5 (middle panels, 100) and E18.5 (right panels, 100). In each panel, proximal is at
the top, distal at the bottom. At E14.5, vascular invasion and cartilage degradation are observed in wild-type (arrowheads) but not yet in
PTHRD/D mutants (insets show the entire bone rudiments).
increased PTH/PTHrP receptor signaling in chondro- in the proliferative versus hypertrophic pools. The PTH/
PTHrP receptor regulates this transition, as documentedcytes and suggest that activation of PLC signaling by
the PTH/PTHrP receptor normally may oppose the domi- previously by the shortened columns of proliferating
chondrocytes and acceleration of hypertrophy observednant net response to receptor activation.
in growth plates of mice lacking either PTHrP or the
PTH/PTHrP receptor (Karaplis et al., 1994; Lanske et al.,Increased Proliferation and Delayed Maturation
1996). To assess the rate of cellular transition from theCause an Accumulation of Columnar Proliferating
proliferating to the hypertrophic stage, we injected preg-Chondrocytes in DSEL Mice
nant mice with a single dose of BrdU 48 hr before sac-The expansion of columnar proliferating chondrocytes
rificing the animals to measure the appearance ofin the growth plates of DSEL mice might reflect an in-
previously labeled cells in the zone of hypertrophiccreased rate of proliferation of these chondrocytes. To
chondrocytes. As expected, hypertrophic chondro-test this hypothesis, we performed pulsed BrdU labeling
cytes, which are postproliferative cells, did not directlyin pregnant mice. Two hours after administration of BrdU
incorporate BrdU, as shown for animals sacrificed 2 hrin vivo at E16.5 or E18.5, the labeling index of cells in
after in vivo BrdU administration (Figures 3D–3F). In wild-the proliferating chondrocyte layer of PTHRD/D mutant
type growth plates analyzed 48 hr after in vivo BrdUembryos was increased by more than 50% compared
administration at E14.5, almost 30% of the hypertrophicto that of wild-type littermates (Figures 3A–3C and data
chondrocytes were labeled (Figure 3H). This labelingnot shown). This finding indicates that increased prolif-
index was decreased by approximately 40% in the hy-eration contributes to the expansion of the zone of co-
pertrophic zone of homozygous PTHRD/D embryos (Fig-lumnar proliferating chondrocytes.
ures 3G–3I). Similar results were found when BrdU wasThe switch from a proliferative to a postproliferative
state is a key determinant of the number of chondrocytes administered at E16.5. Given the previous observation
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Figure 3. BrdU Labeling in Tibia Growth Plate Chondrocytes
BrdU was administered to pregnant mice either 2 hr (A, B, and D–F) or 48 hr (H and I) prior to sacrifice at the gestational ages shown.
Immunohistochemical staining subsequently was performed on sections of the proximal tibiae of wild-type (A, D–F, and H) and PTHRD/D (B
and I) embryos at E14.5 (D), E16.5 (A, B, E, H, and I), or E18.5 (F). BrdU-positive nuclei are stained dark brown. All nuclei are counterstained
with methylene green. BrdU incorporation, calculated as percentage of BrdU-positive nuclei in the periarticular and columnar proliferating
chondrocytes or in the hypertrophic chondrocyte layer, is shown graphically in (C) or (G), respectively. Bars represent means  SD for wild-
type (open bars) and PTHRD/D mutant (solid bars). *P  0.01 (Student’s t test) versus wild-type.
of increased labeling of columnar proliferating chondro- E15.5 metatarsal rudiments from the four expected ge-
notypes in the resulting litters were cultured in serum-cytes, this result points to a considerable delay in hyper-
free medium in vitro. As shown in Figure 4A, mineraliza-trophic differentiation of the proliferating chondrocytes
tion of cartilage, as viewed serially with a dissectingas an additional contributor to the overall accumulation
microscope, gradually expanded distally from the centerof columnar proliferating chondrocytes in DSEL mice.
of the metatarsal rudiments of PTHR/ embryos duringThe delayed hypertrophic differentiation in DSEL mice
4 days in culture. In previous studies in vivo, hemizygousis reflected by the reduced number of hypertrophic cells
PTHR/ mice exhibited normal growth plates (Lanskeobserved early in development (i.e., E14.5 and E15.5;
et al., 1996). In rudiments from PTHR/ mice, mineraliza-Figure 2A). On the other hand, no significant change in
tion was more extensive and extended much fartherthe layer of hypertrophic chondrocytes was observed
toward the articular surfaces, whereas the appearancein more mature bones of DSEL mice, such as E18.5
of mineralized cartilage was greatly delayed in hemizy-metatarsals (Figure 2A) or E15.5 or E18.5 tibiae (Figure
gous PTHRD/ rudiments during this period of culture.2B), suggesting the possibility of an additional delay, in
The eventual appearance of mineralized cartilage after 4more mature bones, in removal of hypertrophic chondro-
days demonstrated that chondrocytes in these PTHRD/cytes by vascular invasion and bone deposition by os-
rudiments ultimately were capable of hypertrophic dif-teoblasts.
ferentiation. The pace of differentiation of heterozygous
PTHR/D rudiments was identical to those from PTHR/
animals. As shown by in situ hybridization (Figure 4B),PLC-Independent Signaling Predominately
Affects Chondrocyte Differentiation hypertrophic cells expressing collagen type X and os-
teopontin occupied large potions of the center ofTo further analyze how specific signaling generated by
the PTH/PTHrP receptor may affect chondrocyte differ- PTHR/ rudiments, and this expression gradually ex-
tended distally. In the hemizygous PTHRD/ rudimentsentiation, PTHR/ and PTHRD/ mice were mated, and
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Figure 4. Development of Cultured Metatarsal Rudiments
Metatarsal bones from animals of the indicated genotypes were isolated and cultured for up to 4 days.
(A) Inverted microscopy (49 magnification) of E15.5 metatarsals cultured for 2, 3, or 4 days. The central dark areas correspond histologically
to zones of mineralized cartilage.
(B) In situ hybridization for collagen type X (bright field images, counterstained with hematoxylin/eosin) or osteopontin (dark field images) in
metatarsals cultured for 3 or 4 days, as indicated (100). Similar observations were made in two different experiments.
at day 3, collagen X expression could be seen in only days with either PTH or the direct PKC activator, tetra-
decanoyl phorbol 13-acetate (TPA). As shown in Figurea few cells near the center, and these did not express
osteopontin, a marker of more advanced chondro- 5A, the domain of chondrocytes expressing collagen
type X and osteopontin was expanded by treatment withcyte hypertrophy. In contrast, hypertrophic cells in the
PTHR/ rudiment at this time already extended abnor- TPA (10 nM). In contrast, hypertrophy of chondrocytes
was inhibited dramatically by PTH in both wild-type andmally close to the ends of the element. After 4 days,
more chondrocytes in the center of the PTHRD/ rudiment PTHRD/D rudiments, and this inhibitory effect was mim-
icked by treatment with forskolin, a stimulator of ade-became hypertrophic and expressed collagen type X and
osteopontin. Thus, in comparison with the PTHR/ rudi- nylyl cyclase (Figure 5B). These results suggest that
PLC/PKC signaling accelerates chondrocyte differentia-ments, the PTHRD/ rudiments demonstrated a striking
delay in chondrocyte differentiation in vitro that con- tion. In contrast, PLC-independent signaling (i.e., the
cAMP/PKA pathway) slows chondrocyte differentiation,trasted sharply with the accelerated differentiation of
PTHR/ tissue. Under these ex vivo culture conditions, and this pathway likely plays a dominant role in normal
regulation of chondrocyte differentiation by PTH/PTHrPpostmature hypertrophic chondrocytes, expressing os-
teopontin but no longer collagen X, accumulate in the receptors.
central portions of the rudiments, which do not undergo
vascular invasion or replacement by primary spongiosa. PLC-Independent Signaling Stimulates
Chondrocyte ProliferationNo type I collagen or osteocalcin could be detected
by in situ hybridization in these osteopontin-expressing In the mice homozygous for ablation of PTHrP, the rate
of chondrocyte proliferation was decreased comparedcells (data not shown). These findings suggest that in
mediating the action of PTHrP, the PTH/PTHrP receptor to wild-type, and this decrease in proliferation could be
restored to wild-type levels by expression of a constitu-exerts both an inhibitory and a stimulatory effect on
differentiation of growth plate chondrocytes, depending tively active PTH/PTHrP receptor transgene (Karp et al.,
2000). This suggests that the PTH/PTHrP receptor ison the specific signals generated by the receptor.
To further examine the roles of PLC-dependent and required for a normal rate of chondrocyte proliferation.
To understand which signaling via the PTH/PTHrP re--independent signaling pathways on regulation of chon-
drocyte differentiation by PTH/PTHrP receptors, cul- ceptor regulates chondrocyte proliferation, we deter-
mined the percentage of chondrocytes incorporatingtured wild-type metatarsal rudiments were treated for 3
Role of PTH/PTHrP Receptor-Phospholipase C In Vivo
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Figure 5. Regulation of Chondrocyte Differentiation in Cultured Metatarsal Rudiments
(A) In situ hybridization of serial sections (100) for collagen type X (bright field, counterstained with hematoxylin/eosin) or osteopontin (dark
field) in E15.5 wild-type or PTHRD/D metatarsals cultured for 3 days in medium alone (Con) or in the presence of TPA (10 nM) or rPTH(1–34)
(100 nM).
(B) Serial microscopic images (49) of E15.5 metatarsals from wild-type or PTHRD/D mice cultured in medium alone (Con) or in the presence
of TPA (10 nM) or forskolin (Fsk, 10 M) for 24, 48, or 72 hr. Similar observations were made in three independent experiments.
BrdU in the cultured metatarsal rudiments after PTH littermates (data not shown). To determine whether in-
creased PTH/PTHrP receptor-dependent cAMP/PKAtreatment. In the wild-type rudiments, as expected,
PTH(1–34) increased the percentage of proliferating signaling, which appears to be linked to chondrocyte
proliferation (Figure 6), might contribute to the increasedchondrocytes in S phase (Figure 6). A comparable in-
crease in BrdU labeling of chondrocytes was observed proliferation observed in chondrocytes of PTHRD/D mice
(Figure 3), we first examined the level of PTH/PTHrPin homozygous PTHRD/D rudiments (Figure 6). This effect
was mimicked by treatment of wild-type rudiments with receptor mRNA by in situ hybridization in tibial growth
plates PTHRD/D mice. These experiments showed that[Gly1, Arg19]hPTH(1–28), a PTH analog that cannot acti-
both the signal intensity and the extent of the domainvate PLC (Takasu et al., 1999b; data not shown). Collec-
expressing high levels of PTH/PTHrP receptor mRNAtively, these results indicate that PLC-independent (i.e,
were increased in the growth plates of PTHRD/D mice,cAMP/PKA-dependent) signaling via the PTH/PTHrP re-
both at E18.5 and at birth (Figures 7A–7H). A similarceptor mediates the proliferative response of growth
increase in intensity and extent of PTH/PTHrP receptorplate chondrocytes.
mRNA was observed in the cultured metatarsal rudi-
ments from PTHRD/D mice (data not shown). To analyze
cell surface expression of the receptor protein in carti-Increased Expression of PTH/PTHrP Receptors
in DSEL Mutant Chondrocytes lage, we isolated primary chondrocytes from tibia, fe-
mur, and fibula at E14.5, a time at which bone formationBecause Ihh is required for normal levels of chondrocyte
proliferation (Karp et al., 2000), we sought effects of the is very limited in limbs, and measured levels of immu-
noreactive PTH/PTHrP receptor using anti-receptorDSEL mutation on hedgehog expression and action. In
tibial growth plates of E18.5 PTHRD/D mice, however, the antibody. As shown in Figure 7I, the expression of immu-
noreactive PTH/PTHrP receptors in DSEL mutant chon-patterns and expression levels of mRNAs encoding Ihh
and its receptor, patched-1, which is upregulated by drocytes was roughly 3-fold that in the wild-type chon-
drocytes. Northern blot analysis further showed thatIhh, appeared indistinguishable from those in wild-type
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Figure 6. Stimulation of Chondrocyte Prolif-
eration by PTH in Cultured Metatarsal Rudi-
ments
Metatarsals isolated on E15.5 from wild-type
(A and B) or PTHRD/D (C and D) mice were
cultured in the presence of 10 nM rPTH(1–34)
(B and D) or vehicle alone (A and C) for 3
days. During the last 6 hr of culture, BrdU (1
mg/ml) was added and incorporated label
was detected immunohistochemically. Label-
ing indices, calculated as the percentages of
BrdU-positive nuclei in the zones comprised
of periarticular or columnar proliferating
chondrocytes, are shown in (E). Bars repre-
sent means  SD for vehicle-treated (open
bars) or PTH-treated (filled bars) rudiments.
*P  0.01 (Student’s t test), compared to
control.
expression of the PTH/PTHrP receptor mRNA in DSEL extend or accelerate chondrocyte proliferation. This has
been inferred from previous analyses of the phenotypesmutant cartilage also was increased relative to that in
the wild-type (data not shown). In parallel cell cultures, of mice in which genes encoding PTHrP or PTH/PTHrP
receptors were ablated (Karaplis et al., 1994; Lanske etthe cAMP response to added PTH was much greater in
cells from PTHRD/D than from wild-type mice (Figure 7J). al., 1996), in which PTHrP was overexpressed in chon-
drocytes (Weir et al., 1996), or in which constitutivelyThese data suggest that PLC-dependent signaling nor-
mally may suppress the level of PTH/PTHrP receptor active PTH/PTHrP receptors could be shown to rescue
the growth plate abnormalities in PTHrP null animalsexpression in growth plate chondrocytes.
(Schipani et al., 1997). The accelerated proliferation and
delayed differentiation are augmented in PTHRD/D mice,Discussion
which provides strong evidence that they are mediated
via PLC-independent signaling mechanisms.PTHRD/D mutant embryos display a delay in both the
hypertrophy of growth plate chondrocytes and the inva- The effect of the DSEL mutation on the size of the
hypertrophic chondrocyte layer changes over time.sion of capillaries into the hypertrophic cartilage, to-
gether with an accumulation of columnar proliferating Early in development, a smaller hypertrophic zone in
PTHRD/D mice is found (e.g., Figure 2A, metatarsals atchondrocytes. These changes are observed early in the
development of a wide range of bones formed via the E14.5 and E15.5). This observation presumably reflects
the delay in exit of chondrocytes from the proliferativeendochondral sequence. The expansion of proliferating
columnar chondrocytes results from both increased pool. After hypertrophic cells start to die in normal mice
(e.g., the tibiae at E14.5 in Figure 2B), there are actuallyproliferation and delayed differentiation into hypertro-
phic chondrocytes. It is notable also that the growth more hypertrophic chondrocytes in the PTHRD/D mice,
presumably because the disappearance of hypertrophicplates of PTHRD/D mice do not exhibit an accumulation
of hypertrophic chondrocytes or mineralized cartilage, chondrocytes has not yet started in these mice. In con-
trast, in E15.5 and E18.5 mice, the size of the hypertro-nor is there an apparent abnormality in formation of
primary spongiosa. Thus, we can conclude also that PLC phic zones in wild-type and PTHRD/D mice are of roughly
similar size. At any time, the extent of the hypertrophicactivation via the PTH/PTHrP receptor is not required for
the resorption of cartilage matrix, local vascular inva- zone depends upon the rate at which new hypertro-
phic cells are formed minus the rate at which hyper-sion, and subsequent formation of primary spongiosa
involved in this orderly developmental progression. trophic cells die or otherwise lose their character as
hypertrophic cells. (The ultimate fate of hypertrophicThese findings in PTHRD/D mutant mice provide insight
into the physiologic regulation of chondrocyte prolifera- chondrocytes still has not been directly demonstrated,
though apoptosis is certainly an important component.)tion and differentiation by PLC-dependent versus PLC-
independent PTH/PTHrP receptor signaling. In mediat- Thus, the normal size of the hypertrophic pool at later
times presumably reflects a balance of hypertrophic celling the actions of PTHrP, chondrocytic PTH/PTHrP re-
ceptors act to slow chondrocyte differentiation and to production and loss.
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Figure 7. PTH/PTHrP Receptor Expression
in Tibial Growth Plates
(A–H) In situ hybridization for PTH/PTHrP re-
ceptors was performed on longitudinal sec-
tions through wild-type and PTHRD/D proximal
tibias at two stages of development (as indi-
cated). After hybridization, sections were
stained with hematoxylin and eosin. (A–D)
bright field; (E–H) dark field. PTH/PTHrP re-
ceptor is expressed in a much broader do-
main and signal is more intense, both at E18.5
(B and F) and in newborn (D and H) tibias, in
PTHRD/D mutants. Similar observations were
made in two independent litters from each
stage of development examined.
(I) Assessment of cell surface PTH/PTHrP re-
ceptor protein in primary chondrocytes. Pri-
mary chondrocytes isolated from wild-type
or PTHRD/D mutant femur, tibia, and fibula at
E14.5 were plated in 24-well plates. After con-
fluence, G48 anti-receptor antibody binding
analysis was performed. Results are ex-
pressed as means  SEM of triplicates (cpm
bound/well). Total (filled bars) and nonspe-
cific (open bars) binding was 2796  76 and
60 12 for the wild-type and 8755 192 and
229  41 for the PTHRD/D mutants, respec-
tively. Protein content (g/well) was 43.4 
3.2 and 48.5  1.5 for the wild-type and
PTHRD/D mutants, respectively. Similar results
were obtained in three independent experi-
ments.
(J) Cyclic AMP stimulation by PTH in primary
chondrocytes. Primary chondrocytes were
isolated as above, and cultured in 24-well
plates for 1 week and then exposed to
rPTH(1–34) at the indicated concentrations for 10 min in the presence of 3-isobutyl-1-methylxanthine (0.5 mM). The responses of wild-type
(open symbols) and PTHRD/D (filled symbols) cells to forskolin (10 M, squares) were also assessed. Results are expressed as means  SEM
of triplicates for pmol/well of cAMP. Similar results were obtained in two experiments.
The action of TPA to accelerate chondrocyte differen- of the PKC activator TPA, to augment differentiation in
tiation in metatarsal bone rudiments from both wild-type metatarsal rudiments in vitro, leaves open the possibility
and PTHRD/D mice suggests that the actions of the DSEL that these modulating effects may result from other
PTH/PTHrP receptor does, in fact, reflect a decrease in downstream transcriptional responses to PLC/PKC acti-
PLC signaling. Our results in vivo, as well as the inhibi- vation in chondrocytes as well. The opposition between
tory actions of forskolin and of the cAMP-selective ana- adenylyl cyclase and PLC activation via the same recep-
log [Gly1,Arg19]hPTH(1–28) upon differentiation observed tor appears paradoxical but may serve to provide in-
in metatarsal rudiments, are most consistent with pri- creased opportunities for regulation. For example, since
mary involvement of the cAMP/PKA pathway in these PLC activation via PTH/PTHrP receptors, relative to that
actions, although it is possible that other PTH/PTHrP- of adenylyl cyclase, is more efficient at higher concen-
dependent signaling events occur and can be transmit- trations of ligand (Guo et al., 1995), we might speculate
ted via DSEL receptors. A major role for cAMP/PKA that PLC activation plays a greater role near the articular
signaling is highlighted also by the recent observation, end of the growth plate, where endogenous PTHrP con-
in a chimeric mouse model, that growth plate chondro- centrations are highest, and could serve to “smoothen”
cytes lacking Gs exhibit accelerated differentiation the functional gradient of PTHrP receptor-mediated de-
(Chung et al., 2000). velopmental regulation.
In contrast, PLC-dependent signaling via the PTH/ Thus, activation of multiple G proteins by the PTH/
PTHrP receptor appears to restrain proliferation of hy- PTHrP receptor in vivo has important physiologic conse-
pertrophic chondrocytes and to stimulate their progres- quences. By extension, it seems likely that other G pro-
sion toward hypertrophic differentiation. These actions tein-coupled receptors also may use multiple signaling
are opposite to the dominant net responses to PTH/ pathways to regulate important physiologic events in
PTHrP activation, as revealed by receptor ablation or vivo.
constitutive activation, which suggests that PLC activa-
tion plays a modulating role that counteracts the major
Experimental Procedureseffects of the cAMP/PKA pathway. Our results suggest
that this effect of PLC activation may be mediated, in Cells
part, by decreased expression of the PTH/PTHrP recep- J1 embryonic stem (ES) cells from 129/SvJ mice were maintained
tor and a corresponding reduction in cAMP/PKA activa- on a layer of irradiated mouse embryonic fibroblasts in ES cell me-
dium, as described previously (Li et al., 1992).tion. On the other hand, our observation of a direct action
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Construction of Targeting Vector Primary Cell and Explant Culture
Primary proximal tubule cells were isolated as described previouslyTo construct the targeting vector, the 13.5 kb EcoRI/EcoRI fragment
of the murine PTH/PTHrP receptor gene was excised from a single (Janulis et al., 1993). Briefly, kidneys from PTHR/, PTHR/D, and
PTHRD/D mice were bisected, the capsule and medulla were re-phage and subcloned into pUC19 (BioLabs) that already contained
a PGKtk gene (2.7 kb HindIII/EcoRI fragment from pPNT) inserted moved, and the cortex then was minced with sharp scissors and
subjected to digestion for 1 hr with type 1 collagenase (Worthingtonat its KpnI site (Lanske et al., 1996). A 4.5 kb KpnI/XhoI fragment
from the 13.5 kb EcoRI/EcoRI subclone then was used to replace Biochemical Corporation; 1 mg/ml) in DMEM medium. Cell aggre-
gates then were dispersed by repeated pipetting, and the resultingthe EKKY sequence in the second intracellular loop of the PTH/
PTHrP receptor with the DSEL mutation (*, Figure 1A). PGKneo cell suspension was passed through an ice-cold mesh (75 m) be-
fore centrifugation at 500 g for 5 min. After washing the digestedresistance expression cassette (1.8 kb XhoI/XbaI fragment from
pPNT) was cloned into the pGEM7 vector with flanking 34 bp loxP cells twice in DMEM medium, they were applied to a preformed
Percoll gradient and centrifuged at 1000 rpm for 1 hr at 4	C to obtainsequences, and then inserted at an EcoRV site. The completed
targeting vector (Figure 1) consisted of a 13.5 kb genomic sequence purified primary proximal tubule cells.
Chondrocytes from embryonic limbs were isolated as describedof the PTH/PTHrP receptor gene incorporating the desired DSEL
mutation, a nearby intronic PGKneo gene (flanked by loxP sites to previously (Guo et al., 2001). Femur, tibia, and fibula at E14.5 were
dissected. After mincing with sharp scissors, the tissue was di-enable positive selection in G418), and a 5 PGKtk gene to allow for
negative selection with gancyclovir. gested for 8 hr with a mixture of type 1 and type 2 collagenase (1:2)
in -MEM medium at a total concentration of 1 mg/ml. Primary
chondrocytes were plated in 6-well or 24-well plates and maintained
Gene Targeting and Blastocyst Injections in -MEM medium supplemented with 8% fetal bovine serum and
The targeting vector (45 g) was linearized with SalI and then elec- antibiotics (50 U/ml of penicillin and 50 g/ml of streptomycin).
troporated into 107 J1 ES cells (Bio-Rad Gene Pulser, 0.24 kV, 0.5 Embryonic metatarsals were dissected and cultured as described
mF). Restriction analysis of DNA from 168 clones resistant to both previously (Haaijman et al., 1999). The second, third, and fourth
G418 and gancyclovir revealed that nine clones had undergone the metatarsals from each embryonic (E15.5) hindlimb were dissected
desired recombination event. From three of these properly targeted under sterile conditions. Each metatarsal was cultured in 300 l of
clones, the PGKneo resistance cassette was removed by Cre-medi- -MEM medium in a separate well of a 24-well plate for up to 4
ated recombination, accomplished by electroporating 106 cells with days without changing the medium. Fresh agonists were added
30 g of an uncut CMV-Cre recombinase expression vector (kindly daily in small volumes. During culture, mineralized cartilage could
provided by Dr. O’Gorman, The Salk Institute for Biological Studies). be recognized under an inverted microscope as a dark area develop-
Ten percent of the Cre-transfected ES clones were correctly tar- ing in the center of the hypertrophic zone, flanked at each end by
geted (59 of 560 clones screened). Four of these correctly targeted a proliferative zone extending to the end of the rudiment.
ES cell lines were microinjected into C57BL/6 blastocysts, which
were implanted into pseudopregnant CD-1 female recipients. Male
Cyclic AMP and IP Assaychimeras were then mated with C57BL/6 females. Germline trans-
Primary proximal tubule cells obtained from PTHR/, PTHR/D, ormission was identified by Southern blot hybridization of tail DNA.
PTHRD/D mice were plated in 24-well or 6-well dishes and culturedAnimals were maintained in facilities operated by the Center for
in DMEM medium (prepared in the Massachusetts General HospitalComparative Research of the Massachusetts General Hospital, and
media kitchen). When confluent, cells were treated with rPTH(1–34)all studies performed were approved by the institution’s Subcommit-
amide for 20 or 40 min for determination of cAMP (Guo et al., 1997),tee on Research Animal Care.
or inositol triphosphate (IP3) (RIA kit, TRK1000; Amersham Life
Science).
Skeletal Staining
Alizarin red and Alcian blue staining was performed as previously Cell Surface Expression of the PTH/PTHrP Receptor
described (Komori et al., 1997). Embryos at E18.5 were fixed at 4	C A PTH/PTHrP receptor-specific antibody was used as previously
for 48 hr in ethanol and then for 24 hr in acetone. Staining was described (Iida-Klein et al., 1997) to measure cell surface expression
performed for 4 days at room temperature. After washing with 95% of wild-type and DSEL mutant receptors. Briefly, primary proximal
ethanol, the skeleton was cleared in 1% KOH and taken through tubule cells and chondrocytes obtained from wild-type or DSEL
graded steps into 100% glycerol. mutant mice were cultured in 24-well plates. When confluent, cells
were washed twice with PBS, incubated at room temperature for 2
hr with sheep anti-rat PTH/PTHrP receptor-specific antibody G48
Histologic Analysis and In Situ Hybridization
(1:500 in PBS with 5% FBS), washed, and then incubated succes-
Embryos at stages E12.5–E18.5, as well as tibiae from postnatal day
sively with second antibody (rabbit anti-sheep IgG; Kirkegaard and
1 through day 120, were dissected in ice-cold PBS, fixed overnight in
Perry Laboratories) and third antibody (goat anti-rabbit 125I-IgG; Du-
4% paraformaldehyde at 4	C, dehydrated, and embedded in paraf-
Pont NEN). Washed cells then were solubilized in 0.5 ml of 0.2 N
fin. Horizontal coronal sections (5 m) were cut and stained with
NaOH/0.1% SDS for determination of radioactivity.
hematoxylin and eosin. In situ hybridization was performed as de-
scribed previously (Chung et al., 2001), using complementary
Acknowledgments35S-labeled riboprobes for mouse type X collagen, mouse osteopon-
tin, and rat PTH/PTHrP receptor (Calvi et al., 2001).
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